Abbott Laboratories (ABT)
104.57
+1.93
(+1.88%)
USD |
NYSE |
Oct 29, 16:00
104.85
+0.28
(+0.27%)
After-Hours: 18:31
Abbott Laboratories Enterprise Value : 205.26B for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 205.26B |
| October 27, 2026 | 206.06B |
| October 26, 2026 | 209.14B |
| October 23, 2026 | 207.10B |
| October 22, 2026 | 205.04B |
| October 21, 2026 | 201.58B |
| October 20, 2026 | 204.93B |
| October 19, 2026 | 207.72B |
| October 16, 2026 | 209.16B |
| October 15, 2026 | 208.79B |
| October 14, 2026 | 205.83B |
| October 13, 2026 | 205.21B |
| October 12, 2026 | 203.84B |
| October 09, 2026 | 200.00B |
| October 08, 2026 | 198.08B |
| October 07, 2026 | 198.50B |
| October 06, 2026 | 197.51B |
| October 05, 2026 | 200.87B |
| October 02, 2026 | 196.37B |
| October 01, 2026 | 194.97B |
| September 30, 2026 | 198.67B |
| September 29, 2026 | 202.34B |
| September 28, 2026 | 202.39B |
| September 25, 2026 | 202.93B |
| September 24, 2026 | 202.55B |
| Date | Value |
|---|---|
| September 23, 2026 | 206.73B |
| September 22, 2026 | 207.08B |
| September 21, 2026 | 205.85B |
| September 18, 2026 | 205.21B |
| September 17, 2026 | 204.55B |
| September 16, 2026 | 204.78B |
| September 15, 2026 | 204.21B |
| September 14, 2026 | 206.04B |
| September 11, 2026 | 204.07B |
| September 10, 2026 | 206.51B |
| September 09, 2026 | 209.75B |
| September 08, 2026 | 210.25B |
| September 04, 2026 | 215.11B |
| September 03, 2026 | 215.91B |
| September 02, 2026 | 218.81B |
| September 01, 2026 | 216.15B |
| August 31, 2026 | 218.62B |
| August 28, 2026 | 222.27B |
| August 27, 2026 | 220.75B |
| August 26, 2026 | 225.09B |
| August 25, 2026 | 228.61B |
| August 24, 2026 | 229.54B |
| August 21, 2026 | 229.49B |
| August 20, 2026 | 225.16B |
| August 19, 2026 | 225.66B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 69.10B |
| Boston Scientific Corp. | 73.60B |
| DexCom, Inc. | 29.12B |
| Globus Medical, Inc. | 10.43B |
| Intuitive Surgical, Inc. | 150.01B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 920.00M |
| Revenue (Quarterly) | 13.01B |
| Total Expenses (Quarterly) | 12.09B |
| EPS Diluted (Quarterly) | 0.5293 |
| Gross Profit Margin (Quarterly) | 57.05% |
| Profit Margin (Quarterly) | 7.07% |
| Earnings Yield | 2.59% |
| Operating Earnings Yield | 3.82% |
| Normalized Earnings Yield | 2.630 |